Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nucleoside-modified RNA for inducing an adaptive immune response

Nucleoside-modified RNA for inducing an adaptive immune response

US Patent 12138305 · Granted Nov 12, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of lipid nanoparticle manufacture and compositions derived therefrom2025
Nucleoside modified mRNA and uses thereof2025
Nucleoside modified mRNA and uses thereof2025
Conserved region T cell vaccines for coronavirus and methods of use2025
Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C viru2025
Compositions for inducing an immune response against zika virus2024
Compositions for inducing an immune response against zika virus2024
Purification and purity assessment of RNA molecules synthesized with modified nu2024
Conserved region T cell vaccines for coronavirus and methods of use2024
RNA containing modified nucleosides and methods of use thereof2023
Modified MRNA vaccines encoding herpes simplex virus glycoproteins and uses ther2023
RNA preparations comprising purified modified RNA for reprogramming cells2023